European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study (EASIC registry)

This study is not yet open for participant recruitment.
Verified January 2011 by Rheumazentrum Ruhrgebiet
Sponsor:
Collaborator:
Centocor Biotech
Information provided by:
Rheumazentrum Ruhrgebiet
ClinicalTrials.gov Identifier:
NCT01286545
First received: January 27, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)